Product
Tetracosactide
Aliases
cosyntropin
Name
Cosyntropin
INN Name
Cosyntropin
FDA Approved
Yes
2 clinical trials
4 organizations
2 indications
3 documents
Indication
Post-dural Puncture HeadacheIndication
Adrenal SuppressionClinical trial
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)Status: Terminated, Estimated PCD: 2022-11-01
Clinical trial
NeSST2: A Multi-stage Clinical Study to Develop a Non-invasive Short Synacthen Test (SST)Status: Recruiting, Estimated PCD: 2025-12-01
Document
DailyMed Label: CosyntropinOrganization
Medical Purchasing Solutions, LLCDocument
DailyMed Label: CortrosynDocument
DailyMed Label: Cortrosyn
Organization
Amphastar Pharmaceuticals, Inc.Organization
HF Acquisition Co LLC, DBA HealthFirstOrganization
Sandoz Inc.